Macquarie Group LTD Tarsus Pharmaceuticals, Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 594,878 shares of TARS stock, worth $32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
594,878
Previous 454,991
30.75%
Holding current value
$32 Million
Previous $12.4 Million
58.22%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
173Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$183 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$176 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$134 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$131 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$121 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.43B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...